Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
6.93
+2.12 (44.07%)
At close: Sep 15, 2025, 4:00 PM EDT
6.65
-0.28 (-4.04%)
After-hours: Sep 15, 2025, 6:24 PM EDT

Monte Rosa Therapeutics Stock Forecast

Stock Price Forecast

The 2 analysts that cover Monte Rosa Therapeutics stock have a consensus rating of "Buy" and an average price target of $13.5, which forecasts a 94.81% increase in the stock price over the next year. The lowest target is $10 and the highest is $17.

Price Target: $13.5 (+94.81%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$10$13.5$17$17
Change+44.30%+94.81%+145.31%+145.31%
* Price targets were last updated on Mar 21, 2025.

Analyst Ratings

The average analyst rating for Monte Rosa Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingApr '25May '25Jun '25Jul '25Aug '25Sep '25
Strong Buy000000
Buy222221
Hold111111
Sell000000
Strong Sell000000
Total333332

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Wells Fargo
Wells Fargo
Hold
Maintains
$11$10
HoldMaintains$11$10+44.30%Mar 21, 2025
Wedbush
Wedbush
Buy
Maintains
$15$17
BuyMaintains$15$17+145.31%Mar 21, 2025
Wells Fargo
Wells Fargo
Hold
Downgrades
$14$11
HoldDowngrades$14$11+58.73%Dec 19, 2024
Wedbush
Wedbush
Buy
Reiterates
$11
BuyReiterates$11+58.73%Sep 12, 2024
Wells Fargo
Wells Fargo
Buy
Maintains
$18$17
BuyMaintains$18$17+145.31%Aug 12, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
138.96M
from 75.62M
Increased by 83.76%
Revenue Next Year
51.39M
from 138.96M
Decreased by -63.02%
EPS This Year
-0.22
from -0.98
EPS Next Year
-1.43
from -0.22
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
----75.62M138.96M51.39M
Revenue Growth
-----83.76%-63.02%
EPS
-23.65-2.96-2.30-2.63-0.98-0.22-1.43
EPS Growth
-------
Forward PE
-------
No. Analysts
-----1010
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High188.3M180.6M
Avg139.0M51.4M
Low105.8Mn/a

Revenue Growth

Revenue Growth20252026202720282029
High
149.0%
30.0%
Avg
83.8%
-63.0%
Low
40.0%
-

EPS Forecast

EPS20252026202720282029
High0.46-0.17
Avg-0.22-1.43
Low-0.53-2.06

EPS Growth

EPS Growth20252026202720282029
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.